NGT HealthCare II is an impact venture capital fund investing and growing startup companies in the fields of biotechnology, pharma, bio-convergence, and medical device.
The former fund, NGTVC invested in 23 medical innovative companies. The second fund, NGT Healthcare II invested already in 22 promising companies.
NGT holds a franchise from the Authority for innovation to operate technological incubator in Nazareth.
Among NGT HealthCare II partners are the Tehnion, Hadasit, IBI, Falcon Group Capital, Jacobs Investment Company, GIG Limited, A3 Investment Group, Arkin Holdings, OurCrowd, Salvador Pascual Sanchez Gijon, Imad and Reem Younis.
NGT HealthCare II management has the experience and expertise in supporting medical startups from identifying breakthrough technologies through R&D, clinical trials, fund raising, all the way to presenting a valuable product to the market. The Fund has a 1,300 square meter facility in Nazareth including laboratories and three clean rooms.
NGT HealthCare II's impact vision is to propel healthcare and life-saving technologies, encourage Arab society and contribute to a stronger economy and an inclusive and equitable Israeli society.